Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, January 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 14,866 followers.

RT @Dr_Ivanoncologo: Interesting article, the #KRAS biomarker is a determinant for treatment with #immunotherapy and other targeted #therap…

RT @Dr_Ivanoncologo: Interesting article, the #KRAS biomarker is a determinant for treatment with #immunotherapy and other targeted #therap…

RT @FrontOncology: New research: Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.